GLP1 Science

Pioneering GLP-1 Research

The first decentralized science DAO tackling the future of metabolic health

GLP-1 agonists like Ozempic and Mounjaro are the fastest-growing drug class globally, with projected combined sales of $129B+ by 2029. Yet, challenges remain—such as enhancing weight-loss efficacy beyond 20% and addressing muscle loss concerns.

Join us in revolutionizing obesity and diabetes treatment through community-driven research.

🗳️ Direct Impact

Shape research priorities and funding decisions with GLP1 tokens

🧬 Research First

Community-driven research initiatives focused on metabolic health

💡 Shared Success

The community benefits directly from valuable research IP and breakthroughs

GLP1 Token Details

Contract Address:
1VHpwkbT3TZ7VjqwrAxvPbQCg2HkBNMrPW2WsQspump

Every day you don't buy GLP1 is another day someone else funds groundbreaking research without you

Elon

Research Initiatives

First study funded! Research begins Jan 2025

Active Research
🐁

FUNDED

Fat Mouse Study

Join Our Community

Note: a minimum balance of 100,000 GLP1 is required to join the token holder TG

Science

GLP1 Scientific Illustration

Glucagon-like peptide-1 (GLP-1) is a hormone that helps regulate blood sugar, appetite, and digestion. It is a hormone your body naturally produces and it can act like a master switch for metabolic health.

Evidence